preludetx.comHealthcareFounded: 2016Funding to Date: $95MM
Prelude Therapeutics is a clinical-stage precision oncology company focused on discovering and developing small molecule therapies optimized to target the key driver mechanisms in cancers with high unmet need.
View Enterprise Value for Prelude Therapeutics.